InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,595.76
(
0.75%
)
US TECH 100
18,955.20
(
0.14%
)
Dow Jones
41,096.77
(
0.58%
)
Brent Oil
72.34
(
0.51%
)
Bitcoin
58,311.62
(
0.30%
)
Post# of 253104
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 839
Posts 120415
Boards Moderated 18
Alias Born 09/05/2002

DewDiligence

Member Level

Re: mcbio post# 114435

Monday, 02/28/2011 4:50:59 PM

Monday, February 28, 2011 4:50:59 PM

Post# of 253104
To lift the partial FDA clinical hold on IDX184, the FDA will need to see no safety signal in the 28-day data for the first 30 patients to enroll in the phase-2b trial in treatment-naïve genotype-1 patients slated to begin in 2H11. In other words, it will likely be 2012 before the partial clinical hold can be lifted. (Source: Today’s CC)

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up